reference/36356890

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36356890

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	110
issn	0270-4137 1097-0045
issueIdentifier	1
pageRange	100-110
publicationName	The Prostate
startingPage	100
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bab3e2b559bbde17164a82db50415d35 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4c4f4a6c5972ec75e3fd979c7098e660 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d62f51386142d8e7576b9b70134d6e59
bibliographicCitation	Labrecque MP, Brown LG, Coleman IM, Nguyen HM, Dalrymple S, Brennen WN, Isaacs JT, Li D, Lakely B, DeLucia DC, Lee JK, Schweizer MT, Lin DW, Corey E, Nelson PS, Morrissey C. Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer. Prostate. 2024 Jan;84(1):100–10. PMID: 37796107; PMCID: PMC10851871.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9807-7433 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e08a33c0c490e4bbca20b8f4b543fbc7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fccb84aafd4241b9b4b781bc7fa3cfb1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8503e1fbf599dd58d01d42e396fa2f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc0cb91723fff84814f2e4a3c1b5dc9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30f36896f30454455ff035306aa2ab80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9244-3807 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7887-7599 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d4c89b6b6229cc0b038aaf50b17ae01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3854-4658 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d51e4314d21fe6892eb1f6946602ee00 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e12ba7f2480396c08817594f197833ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1906-5333 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df0135544904ca9ecdbb879382334622 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a03a08e3a1e18e08d53e5959577abb22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f
date	2023-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/37796107 https://pubmed.ncbi.nlm.nih.gov/PMC10851871 https://doi.org/10.1002/pros.24630
isPartOf	https://portal.issn.org/resource/ISSN/1097-0045 https://portal.issn.org/resource/ISSN/0270-4137 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6523
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Targeting the fibroblast growth factor pathway in molecular subtypes of castration‐resistant prostate cancer
discusses	http://id.nlm.nih.gov/mesh/M0545741 http://id.nlm.nih.gov/mesh/M0014878 http://id.nlm.nih.gov/mesh/M0001106 http://id.nlm.nih.gov/mesh/M0008437 http://id.nlm.nih.gov/mesh/M0018556
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D064129Q000188 http://id.nlm.nih.gov/mesh/D064129Q000235 http://id.nlm.nih.gov/mesh/D064129Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D005346Q000494 http://id.nlm.nih.gov/mesh/D011944Q000378 http://id.nlm.nih.gov/mesh/D000728Q000494 http://id.nlm.nih.gov/mesh/D009570Q000494 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D059002Q000494 http://id.nlm.nih.gov/mesh/D005346Q000235 http://id.nlm.nih.gov/mesh/D011944Q000235 http://id.nlm.nih.gov/mesh/D015398

Total number of triples: 59.